✦ LIBER ✦

Second-line treatment forHelicobacter pyloriinfection based on moxifloxacin triple therapy: a randomized controlled trial

✍ Scribed by Josip Bago; Branko Pevec; Monika Tomić; Marinko Marušić; Vinko Bakula; Petra Bago

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Advantages of Moxifloxacin and Levofloxa

✍ Yuqin Li; Xiayue Huang; Linhua Yao; Ruihua Shi; Guoxin Zhang 📂 Article 📅 2010 🏛 Springer Vienna 🌐 English ⚖ 748 KB

244 A Randomized Controlled Trial of Tri

✍ Ang, Tiing Leong; Fock, Kwong Ming; Ang, Daphne 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 67 KB

568 An Update: A Randomized Controlled T

✍ Song, Mingjun; Ang, Tiing Leong; Fock, Kwong Ming 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 407 KB

Levofloxacin-based and clarithromycin-ba

✍ Liou, J. M.; Lin, J. T.; Chang, C. Y.; Chen, M. J.; Cheng, T. Y.; Lee, Y. C.; Ch 📂 Article 📅 2010 🏛 BMJ Publishing Group 🌐 English ⚖ 201 KB

One-week ranitidine bismuth citrate vers

✍ Nelson N.S Kung; Joseph J.Y Sung; Nancy W.F Yuen; T.H Li; P.W Ng; W.M Lai; Y.H L 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 43 KB

Ramucirumab plus docetaxel versus placeb

✍ Garon, Edward B (author);Ciuleanu, Tudor-Eliade (author);Arrieta, Oscar (author) 📂 Article 📅 2014 🏛 Elsevier BV 🌐 English ⚖ 389 KB